CONTRACEPTIVES MARKET ANALYSIS

Market News

Global Contraceptive Market- Recent Developments

Product Launch

• On July 13, 2023, Perrigo Company plc., one of the leading providers of Consumer Self-Care Products announced that the U.S. Food and Drug Administration (FDA) approved Opill, a progestin-only daily oral contraceptive, for over-the-counter (OTC) use for all ages. Opill is the first ever birth control pill available over the counter in the U.S.
• On July 13, 2023, the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy, the first daily oral contraceptive approved for use in the U.S. without a prescription.

Acquisition and Partnership

• On December 12, 2023, Aditxt, Inc., a company dedicated in discovering, developing, and deploying promising health innovations, and Evofem Biosciences, Inc., a pioneer in women’s health announced the signing of a definitive agreement under which Aditxt Inc. acquired Evofem Biosciences, Inc. Evofem Biosciences, Inc., is the creator of the first and only U.S.FDA-approved hormone-free contraceptive gel, Phexxi (lactic acid, citric acid, and potassium bitartrate).
• On June 21, 2023, Biden-Harris Administration, presidential administration of the United States led by President Joe Biden and Vice President Kamala Harris announced a public-private partnership between the U.S. Department of Health and Human Services (HHS) and Upstream to expand access to contraception, an essential component of reproductive health care, and address the growing disparities in women’s health in the U.S.